Etofamide
 | |
| Systematic (IUPAC) name | |
|---|---|
| 2,2-dichloro-N-(2-ethoxyethyl)-N- [4-(4-nitrophenoxy)benzyl]acetamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| |
| Oral | |
| Identifiers | |
25287-60-9  | |
| P01AC03 | |
| PubChem | CID 65718 |
| ChemSpider | 59142 |
| UNII |
03F36JH21U |
| KEGG |
D07355 |
| Chemical data | |
| Formula | C19H20Cl2N2O5 |
| 427.27 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Etofamide (INN, also known as eticlordifene) is an antiprotozoal drug used in the treatment of amoebiasis.
Its effect against Giardia lamblia has been described as modest.[1]
References
- ↑ Cedillo-Rivera R, Muñoz O (September 1992). "In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents". J. Med. Microbiol. 37 (3): 221–4. doi:10.1099/00222615-37-3-221. PMID 1518040.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||